| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 橘红系列(元) | 109,832,030.12 | 216,937,946.03 | 113,941,840.88 | 91,030,573.57 | 45,566,636.92 |
| 抗病毒口服液(元) | 101,129,201.11 | 430,096,337.89 | 288,282,459.16 | 177,117,830.12 | 67,637,027.95 |
| 中药材(元) | 445,203,119.57 | 744,752,704.30 | 343,333,501.28 | 924,373,742.58 | 533,353,425.19 |
| 其他(元) | 440,378,478.70 | 907,500,694.31 | 455,794,687.27 | 994,547,755.13 | 544,431,170.18 |
| 营业成本(元) | |||||
| 橘红系列(元) | 45,639,703.80 | 96,720,997.82 | - | 40,342,459.80 | - |
| 抗病毒口服液(元) | 77,873,490.68 | 248,913,243.42 | 144,002,232.04 | 142,829,871.38 | - |
| 中药材(元) | 309,587,287.07 | 504,079,016.03 | 235,284,211.10 | 671,095,691.10 | 403,024,792.75 |
| 其他(元) | 301,036,915.20 | 659,807,993.99 | - | 790,289,042.97 | - |
| 毛利(元) | |||||
| 橘红系列(元) | 64,192,326.32 | 120,216,948.21 | - | 50,688,113.77 | - |
| 抗病毒口服液(元) | 23,255,710.43 | 181,183,094.47 | 144,280,227.12 | 34,287,958.74 | - |
| 中药材(元) | 135,615,832.50 | 240,673,688.27 | 108,049,290.18 | 253,278,051.48 | 130,328,632.44 |
| 其他(元) | 139,341,563.50 | 247,692,700.32 | - | 204,258,712.16 | - |
| 毛利率(%) | |||||
| 橘红系列(%) | 58.45 | 55.42 | - | 55.68 | - |
| 抗病毒口服液(%) | 23.00 | 42.13 | 50.05 | 19.36 | - |
| 中药材(%) | 30.46 | 32.32 | 31.47 | 27.40 | 24.44 |
| 其他(%) | 31.64 | 27.29 | - | 20.54 | - |
| 收入构成(%) | |||||
| 橘红系列(%) | 10.02 | 9.44 | 9.48 | 4.16 | 3.83 |
| 抗病毒口服液(%) | 9.22 | 18.71 | 24.00 | 8.10 | 5.68 |
| 中药材(%) | 40.60 | 32.39 | 28.58 | 42.27 | 44.78 |
| 其他(%) | 40.16 | 39.47 | 37.94 | 45.47 | 45.71 |
| 毛利构成(%) | |||||
| 橘红系列(%) | 17.71 | 15.22 | 0.00 | 9.34 | 0.00 |
| 抗病毒口服液(%) | 6.42 | 22.94 | 57.18 | 6.32 | 0.00 |
| 中药材(%) | 37.42 | 30.47 | 42.82 | 46.69 | 100.00 |
| 其他(%) | 38.45 | 31.36 | 0.00 | 37.65 | 0.00 |